Travere Therapeutics, Inc. (TVTX)
NASDAQ·Healthcare·Biotechnology
$56.60
+3.00%
Mkt Cap $5.17B
Analyst Ratings
Buy
21
Hold
1
Sell
0
Price Target (21 analysts)
$60.33
Range $49.00 – $67.00
Implied Upside
+6.6%
Consensus $60.33 vs current $56.60
NASDAQ·Healthcare·Biotechnology
$56.60
+3.00%
Mkt Cap $5.17B
Buy
21
Hold
1
Sell
0
Price Target (21 analysts)
$60.33
Range $49.00 – $67.00
+6.6%
Consensus $60.33 vs current $56.60